Home > Financial Ratios > CORONA REMEDIES

CORONA REMEDIES
Working Capital/Sales

    Back to All Ratios
CORONA REMEDIES is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for CORONA REMEDIES
Please provide your vote to see the results

CORONA REMEDIES Last 5 Year Working Capital/Sales History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023
   Working Capital/Sales(x) -107.2611.8415.785.83

What is the latest Working Capital/Sales ratio of CORONA REMEDIES ?

The latest Working Capital/Sales ratio of CORONA REMEDIES is -107.26 based on Mar2026 Consolidated results.
Year Working Capital/Sales
Mar2026-107.26
Mar202511.84
Mar202415.78
Mar20235.83

How is Working Capital/Sales of CORONA REMEDIES Trending?

Years Working Capital/Sales % Change
Mar2026 -107.26
Negative
Mar2025 11.84
-24.97
Mar2024 15.78
170.67
Mar2023 5.83 -

Other Financial Ratios of CORONA REMEDIES


Compare Working Capital/Sales ratio of peers of CORONA REMEDIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
CORONA REMEDIES ₹12,611.2 Cr 3.7% -7.9% NA Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹419,620.0 Cr -0.2% -5.1% 8.4% Stock Analytics
DIVIS LABORATORIES ₹239,714.0 Cr -3.8% -3.2% 51.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹174,741.0 Cr -1.7% -7.7% 29.9% Stock Analytics
CIPLA ₹106,061.0 Cr 0.6% -3.8% -11% Stock Analytics
DR REDDYS LABORATORIES ₹101,339.0 Cr 2.9% 4.6% 0.4% Stock Analytics


CORONA REMEDIES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
CORONA REMEDIES

3.7%

-7.9%

NA
SENSEX

0.2%

-2.8%

-11.2%


You may also like the below Video Courses